Mougui Ahmed, Baba Zineb, Hmamouchi Ihsane, Abouqal Redouane, Bezza Ahmed, Allali Fadoua, Bahiri Rachid, Ghozlani Imad, Hassikou Hasna, Ichchou Linda, Janani Saadia, Harzy Taoufik, Niamane Redouane, El Maghraoui Abdellah, El Bouchti Imane
Rheumatology, EzarriHospital, Faculty of Medicine and Pharmacy of Marrakech, Mohammed VI University Hospital, Marrakech, MAR.
Rheumatology, Arrazi Hospital, Faculty of Medicine and Pharmacy of Marrakech, Mohammed VI University Hospital, Marrakech, MAR.
Cureus. 2023 May 16;15(5):e39100. doi: 10.7759/cureus.39100. eCollection 2023 May.
Introduction The Assessment of SpondyloArthritis International Society (ASAS) criteria for axial and peripheral spondyloarthritis (SpA) allow for the classification of patients with an age of onset of disease of less than 45 years. However, SpA can start after this age. This study aimed to assess the characteristics of late-onset SpA (SpA>45 years) in the Moroccan registry of biological therapies in rheumatic diseases (RBSMR). Methods A cross-sectional study was conducted using the baseline data of the RBSMR. The protocol for the original RBSMR study was reviewed and approved by the Ethics Committee for Biomedical Research Mohammed V University - Rabat, Faculty of Medicine and Pharmacy of Rabat (approval number for the study was 958/09/19, and the date of approval was September 11, 2019), and all patients had given their written consent. Patients who met the 2009 ASAS criteria for SpA were included. They were divided into two groups: early-onset SpA (≤ 45 years) and late-onset SpA (>45 years). Clinical, biological, radiological, and therapy data of the two groups were compared. Statistical analysis was performed using SPSS v25 software (IBM Corp. Armonk, NY). Parameters with a p-value ≤0.05 were considered significant. Results Our population consisted of 194 patients. Thirty-one patients (16%) had late-onset SpA. Comparison between patients with early-onset (≤45 years) and late-onset SpA (>45 years) revealed that late-onset SpA had a higher tender joint count (p=0.01), a higher swollen joint count (p=0.02), depression (p=0.00), fibromyalgia (p=0.001), hypercholesterolemia (p=0.01), and a lower frequency of coxitis (p=0.008). Logistic regression analysis confirmed that late-onset SpA was associated with a higher tender joint count (OR=0.93, CI 95%: 0.88-0.98), a higher swollen joint count (OR=0.92, CI 95%: 0.85-0.99), depression ( OR=0.19, CI 95%:0.04-0.38), fibromyalgia (OR=1.75, CI 95%: 1.74-17.85), and a lower frequency of coxitis ( OR=0.29, CI 95%: 0.11-0.75). Conclusion As life expectancy increases, late-onset SpA will become increasingly common. It is therefore imperative to determine its characteristics. In the RBSMR study, late-onset SpA was associated with a high number of tender and swollen joints, depression, fibromyalgia, and a lower frequency of coxitis.
引言 国际脊柱关节炎评估协会(ASAS)的轴性和外周性脊柱关节炎(SpA)标准适用于发病年龄小于45岁的患者分类。然而,SpA可在该年龄之后发病。本研究旨在评估摩洛哥风湿性疾病生物治疗登记处(RBSMR)中晚发性SpA(SpA>45岁)的特征。方法 采用RBSMR的基线数据进行横断面研究。RBSMR原始研究方案经拉巴特穆罕默德五世大学医学院和药学院生物医学研究伦理委员会审查并批准(研究批准号为958/09/19,批准日期为2019年9月11日),所有患者均已签署书面同意书。纳入符合2009年ASAS SpA标准的患者。他们被分为两组:早发性SpA(≤45岁)和晚发性SpA(>45岁)。比较两组的临床、生物学、放射学和治疗数据。使用SPSS v25软件(IBM公司,纽约州阿蒙克)进行统计分析。p值≤0.05的参数被认为具有统计学意义。结果 我们的研究对象包括194例患者。31例患者(16%)患有晚发性SpA。早发性(≤45岁)和晚发性SpA(>45岁)患者的比较显示,晚发性SpA的压痛关节数较多(p=0.01)、肿胀关节数较多(p=0.02)、存在抑郁(p=0.00)、纤维肌痛(p=0.001)、高胆固醇血症(p=0.01),且髋关节炎发生率较低(p=0.008)。逻辑回归分析证实,晚发性SpA与较高的压痛关节数(OR=0.93,95%CI:0.88-0.98)、较高的肿胀关节数(OR=0.92,95%CI:0.85-0.99)、抑郁(OR=0.19,95%CI:0.04-0.38)、纤维肌痛(OR=1.75,95%CI:1.74-17.85)以及较低的髋关节炎发生率(OR=0.29,95%CI:0.11-0.75)相关。结论 随着预期寿命的增加,晚发性SpA将变得越来越普遍。因此,确定其特征势在必行。在RBSMR研究中,晚发性SpA与大量压痛和肿胀关节、抑郁、纤维肌痛以及较低的髋关节炎发生率相关。